Shopping Cart
- Remove All
- Your shopping cart is currently empty
Sabatolimab (MBG453), a humanized IgG4 (S228P) antibody targeting TIM-3, is a potent inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab has potential immunosuppressive activity and selectively binds to TIM-3 on immune cells and bone marrow cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 169 € | In Stock | |
5 mg | 511 € | In Stock | |
10 mg | 867 € | In Stock |
Description | Sabatolimab (MBG453), a humanized IgG4 (S228P) antibody targeting TIM-3, is a potent inhibitory receptor that regulates adaptive and innate immune responses. Sabatolimab has potential immunosuppressive activity and selectively binds to TIM-3 on immune cells and bone marrow cells. |
Alias | NVP-MBG453, MBG453 |
Molecular Weight | 145 kDa (average) |
Cas No. | 2252262-24-9 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.